← Back to Search

Resveratrol Supplement

ResArgin for Weight Loss

N/A
Waitlist Available
Research Sponsored by Dr. Heather Hausenblaus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age range between 25 to 60 years
Be between 18 and 65 years old
Must not have
Metabolic or endocrine related dysregulation including but not limited to: diagnosis of type I or type II diabetes, liver, kidney, or pancreatic dysfunction
History of seizures or epilepsy-related disorders
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to day 90
Awards & highlights

Summary

"This trial aims to see if a supplement called ResArgin can help slow down muscle loss during a period of fat loss. It will also assess other health outcomes like sleep, mood, and activity.

Who is the study for?
This trial is for adults looking to lose weight without losing muscle. Participants must be willing to take a daily supplement (ResArgin or placebo) and keep a diary of their mood and health for 3 months. Specific inclusion and exclusion criteria are not provided, but typically involve age, health status, and commitment to the study protocol.
What is being tested?
The trial tests if ResArgin can help maintain muscle during weight loss compared to a placebo. It also examines whether ResArgin affects sleep quality, activity levels, mood, and body satisfaction over three monthly assessments.
What are the potential side effects?
Potential side effects are not listed; however, as with any supplement, there could be risks of allergic reactions or gastrointestinal issues. The impact on sleep patterns and mood will also be monitored as possible side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 25 and 60 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have diabetes or problems with my liver, kidney, or pancreas.
Select...
I have a history of seizures or epilepsy.
Select...
I have musculoskeletal issues that limit my physical activity.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to day 90
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to day 90 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Body composition change from baseline in fat mass and fat free mass as assessed by a DEXA scan at 90 days
Secondary study objectives
Change from baseline in health-related quality of life, sleep quality, activity, and mood at 90 days

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: ResArginActive Control1 Intervention
A resveratrol-based supplement. Participants will receive a daily oral dose of ResArgin containing \[50 mg/d\] of trans-Resveratrol for 90 days.
Group II: placeboPlacebo Group1 Intervention
Placebo consists of oat hull. Participants receive a daily oral dose of a placebo matching the appearance and dosage form of ResArgin for 90 days.

Find a Location

Who is running the clinical trial?

Dr. Heather HausenblausLead Sponsor
~20 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top